Skip to main content

Clinical Trials › NCT06564311

Active, Not RecruitingPhase 2

A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

Sponsored by Zenas BioPharma (USA), LLC

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
93
Target enrollment
11
U.S. states
Aug 2024
Start date
Feb 2026
Expected completion

Interventions / Treatments

ObexelimabPlacebo

Conditions studied

Relapsing Multiple Sclerosis

Where this trial is running (14 sites)

Arizona2 sites
Phoenix · Scottsdale
Florida2 sites
Naples · Tampa
Wisconsin2 sites
Greenfield · Milwaukee
Alabama1 site
Cullman
West Hollywood
Worcester
Minnesota1 site
Plymouth
Missouri1 site
St Louis
Teaneck
Ohio1 site
Columbus
Texas1 site
Plano

MS centers in Arizona

Compare treatment centers near a trial site by center type, providers and trials.

View Arizona centers

More Phase 2 trials

Browse all Phase 2 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play